Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey

Autor: Radfar, SR, De Jong, CAJ, Farhoudian, A, Ebrahimi, M, Rafei, P, Vahidi, M, Yunesian, M, Kouimtsidis, C, Arunogiri, S, Massah, O, Deylamizadeh, A, Brady, KT, Busse, A, Potenza, MN, Ekhtiari, H, Baldacchino, AM, Abagiu, AO, Abouna, FDN, Ahmed, MH, Al-ansari, B, Abu Al-khair, F Mahmmoud, Almaqbali, MH, Ambekar, A, Ardabili, HM, Arya, S, Lasebikan, VO, Ayasreh, MA, Basu, D, Benmebarek, Z, Bhad, R, Blaise, M, Bonnet, N, Brasch, J, Broers, B, Butner, JL, Camilleri, M, Campello, G, Carra, G, Celic, I, Chalabianloo, F, Chaturvedi, A, de Jesús Eduardo Noyola Cherpitel, J, Clark, KJ, Cyders, MA, de Bernardis, E, Derry, JE, Dhagudu, NK, Dolezalova, P, Dom, G, Dunlop, AJ, Elhabiby, MM, Elkholy, H, Essien, NF, Farah, GI, Ferri, M, Floros, GD, Friedman, C, Fuderanan, CH, Gerra, G, Ghosh, A, Gogia, M, Grammatikopoulos, IA, Grandinetti, P, Guirguis, A, Gutnisky, D, Haber, PS, Hassani-Abharian, P, Hooshyari, Z, Ibrahim, IIM, Ieong, HFH, Indradewi, RN, Iskandar, S, Jain, S, James, Sandi, Javadi, SMH, Joe, KH, Jokubonis, D, Jovanova, AT, Kamal, RM, Kantchelov, AI, Kathiresan, P, Katzman, G, Kawale, P, Kern, AM, Kessler, FHP, Kim, SGS, Kimball, AM, Kljucevic, Z, Siste, K, Lev, R, Lee, HK, Lengvenyte, A, Lev-ran, S, Mabelya, GS, Mahi, MAE, Maphisa, JM, Maremmani, I, Masferrer, L, McCambridge, O, McGovern, GG

Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announceme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60e87cff5203a211871e6640997bfc3a

Clinical progress note: Xylazine use and its sequelae.

Autor: Allcroft H; Yale Physician Associate Program, New Haven, Connecticut, USA.; Yale School of Public Health, New Haven, Connecticut, USA., Heiman E; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Butner JL; Yale School of Public Health, New Haven, Connecticut, USA.; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

Publikováno v: Journal of hospital medicine [J Hosp Med] 2024 Aug; Vol. 19 (8), pp. 713-715. Date of Electronic Publication: 2024 Apr 01.

World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys.

Autor: Ekhtiari H; Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States.; Laureate Institute for Brain Research, Tulsa, OK, United States., Khojasteh Zonoozi A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rafei P; Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland., Abolghasemi FS; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Pemstein D; Political Science and Public Policy & Challey Institute, North Dakota State University, Fargo, ND, United States., Abdelgawad T; Faculty of Medicine, Cairo University, Cairo, Egypt., Achab S; Faculty of Medicine, Sociological and Psychological Research Unit, Department of Psychiatry, University of Geneva, Geneva, Switzerland., Ghafri HA; National Rehabilitation Center, Abu Dhabi, United Arab Emirates., Al'Absi M; Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States., Bisch M; Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France., Conti AA; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Ambekar A; National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India., Arunogiri S; Monash Addiction Research Centre, Eastern Health Clinical School, Melbourne, VIC, Australia., Bhad R; National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India., Bilici R; Faculty of Medicine, Department of Psychology, Istanbul Ticaret University, Istanbul, Türkiye., Brady K; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States., Bunt G; School of Medicine, New York University, New York City, NY, United States., Busse A; Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria., Butner JL; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States., Danesh A; Division of Prevention Science, University of California, San Francisco, San Francisco, CA, United States., El-Khoury J; Lebanese Psychiatric Society, Beirut, Lebanon., Omari FE; Faculty of Medicine, University Mohammed Vth of Rabat, Rabat, Morocco., Jokūbonis D; Republican Center for Addictive Disorders, Lithuanian University of Health Sciences, Kaunas, Lithuania., de Jong C; Behavioral Science Institute, Radboud University, Nijmegen, Netherlands., Dom G; Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium., Ebrahimi M; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Fathi Jouzdani A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Ferri M; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal., Galea-Singer S; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.; National Health Service (NHS) Fife Addiction Services, Cameron Hospital, Windygates, United Kingdom., Parker DG; School of Public Health, National University of Cordoba, Cordoba, Argentina., Higuchi S; National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan., Kathiresan P; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Khelifa E; Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia., Kouimtsidis C; National Office for Addressing Drugs, Athens, Greece.; Surrey and Borders Partnership, National Health Service (NHS) Foundation Trust, Leatherhead, United Kingdom.; Department of Medicine, Imperial College London, London, United Kingdom., Krupitsky EM; Department of Addictions, Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia., Long J; Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Maremmani I; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.; UniCamillus, International Medical University in Rome, Rome, Italy., McGovern G; Irish Chapter of International Society of Addiction Medicine (IRE-ISAM), Dublin, Ireland., Mohaddes Ardabili H; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rahimi-Movaghar A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Rataemane ST; Department of Psychiatry, University of Limpopo, Polokwane, South Africa., Sangchooli A; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia., Sibeko G; Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa., Vella AM; Foundation for Social Welfare Services (FSWS), Sedqa, Santa Venera, Malta., Vista SBD; Department of Psychiatry and Behavioral Medicine, College of Medicine and Philippines General Hospital, University of the Philippines Manila, Manila, Philippines., Zare-Bidoky M; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Zhao M; Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China., Javed A; Pakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan., Potenza MN; Department of Psychiatry and Child Center, Yale School of Medicine, New Haven, CT, United States.; Connecticut Mental Health Center, New Haven, CT, United States.; Connecticut Council on Problem Gambling, Wethersfield, CT, United States.; Wu Tsai Institute and Department of Neuroscience, Yale University, New Haven, CT, United States., Baldacchino AM; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2024 Mar 11; Vol. 15, pp. 1230318. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).

Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review.

Autor: Tay Wee Teck J; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, UK.; Forward Leeds and Humankind Charity, Durham, UK., Butner JL; Department of Medicine, Yale University School of Medicine, New Haven, CT, USA., Baldacchino A; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, UK.

Publikováno v: Journal of telemedicine and telecare [J Telemed Telecare] 2023 Sep 04, pp. 1357633X231195607. Date of Electronic Publication: 2023 Sep 04.

Tramadol, captagon and khat use in the Eastern Mediterranean Region: opening Pandora's box.

Autor: Mohaddes Ardabili H; Psychiatry Resident, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; and International Society of Addiction Medicine New Professionals Exploration, Training & Education Committee (ISAM NExT), Calgary, Canada., Akbari A; Medical Student, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rafei P; MSc. Clinical Psychology, Department of Psychology, Faculty of Psychology and Education, University of Tehran, Iran; and International Society of Addiction Medicine New Professionals Exploration, Training & Education Committee (ISAM NExT), Calgary, Canada., Butner JL; Addiction Medicine Specialist, International Society of Addiction Medicine New Professionals Exploration, Training & Education Committee (ISAM NExT), Calgary, Canada., Khan R; Professor, Psychiatry Specialist, Department of Psychiatry, Frontier Medical College, Affiliated to Bahria University, Abbottabad, Pakistan., Khazaal Y; Full Professor of Addiction Psychiatry, Addiction Medicine, Department of Psychiatry, Lausanne University Hospital and Lausanne University, Switzerland., Arab AZ; PG Researcher, Division of Systems Medicine, School of Medicine, University of Dundee, UK., Qazizada MR; Dr., Communicable Diseases Control Directorate, National AIDs Control Program, Communicable Diseases Control Directorate, Ministry of Public Health, Kabul, Afghanistan., Al-Ansari B; PhD Addiction Medicine, Addiction Medicine, Sydney Medical School, University of Sydney, NSW, Australia., Baldacchino AM; Medicine, Psychiatry and Addictions Professor, Division of Population and Behavioural Science, School of Medicine, University of St Andrews, UK. Email amb30@st-andrews.ac.uk.

Publikováno v: BJPsych international [BJPsych Int] 2022 Aug; Vol. 19 (3), pp. 58-62.